Acro Biomedical (ACBM) Beginning Cash Balance (2018 - 2019)

Acro Biomedical (ACBM) recorded quarterly Beginning Cash Balance of $50000.0 in Q4 2019, up 11.11% quarter-over-quarter from $45000.0 in Q3 2019, and down 64.62% on a YoY basis from $141336.0 in Q4 2018.

Acro Biomedical (ACBM) Beginning Cash Balance (2018 - 2019) Analysis & Trends

Acro Biomedical's Beginning Cash Balance history runs 2 years deep, the most recent figure standing at $50000.0 for Q4 2019.

  • In Q4 2019, Beginning Cash Balance fell 64.62% year-over-year to $50000.0; the TTM figure through Sep 2022 stood at $95000.0 (changed 0.0% YoY), while the FY2019 annual figure was $95001.0, changed N/A from the prior year.
  • Beginning Cash Balance was $50000.0 for Q4 2019 at Acro Biomedical, up from $45000.0 in the prior quarter.
  • In the past five years, Beginning Cash Balance ranged from a high of $141336.0 in Q4 2018 to a low of $45000.0 in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 EQV Ventures Acquisition 477.93 Mn 477.93 Mn -
2 GP-Act III Acquisition 312.80 Mn 312.80 Mn -
3 Berto Acquisition 311.56 Mn 311.56 Mn -
4 Churchill Capital Corp IX 310.79 Mn 310.79 Mn -
5 Centurion Acquisition 310.21 Mn 310.21 Mn -
6 WEN Acquisition 309.15 Mn 309.15 Mn -
7 Agriculture & Natural Solutions Acquisition 303.81 Mn 303.81 Mn -
8 Bold Eagle Acquisition 274.64 Mn 274.64 Mn -
9 Live Oak Acquisition Corp. V 265.88 Mn 265.88 Mn -
10 Acro Biomedical - - -

Historic Data

Download Data
DateValue
Dec 31, 2019 50,000.00
Dec 31, 2019 50,000.00
Sep 30, 2019 45,000.00
Sep 30, 2019 45,000.00
Dec 31, 2018 141,336.00
Dec 31, 2018 141,336.00